We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.83%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$40.5B
AUM Growth
+$7.82B
(+24%)
Cap. Flow
+$9.9B
Cap. Flow
% of AUM
24.45%
Top 10 Holdings %
Top 10 Hldgs %
11.2%
Holding
4,410
New
905
Increased
1,516
Reduced
1,218
Closed
685
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$184M |
| 2 |
Dollar General
DG
|
+$152M |
| 3 |
MongoDB
MDB
|
+$129M |
| 4 |
Starbucks
SBUX
|
+$126M |
| 5 |
Costco
COST
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$111M |
| 2 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$97.7M |
| 3 |
Automatic Data Processing
ADP
|
+$90.7M |
| 4 |
Phillips 66
PSX
|
+$82.6M |
| 5 |
CVS Health
CVS
|
+$82.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 5.7% |
| 4 | Healthcare | 5.63% |
| 5 | Industrials | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Tenaya Therapeutics
TNYA
$168M
| $69.3K | ﹤0.01% |
+27,183
| New | +$114K |
|
3602
The RealReal
REAL
$1.34B
| $68.2K | ﹤0.01% |
32,322
+1,317
| +4% | +$3.21K |
|
|
GOL
3603
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $68K | ﹤0.01% |
24,827
-28,733
| -54% | -$102K |
|
3604
Lexicon Pharmaceuticals
LXRX
$1.02B
| $67.8K | ﹤0.01% |
+62,243
| New | +$109K |
|
3605
CarParts.com
PRTS
$42.8M
| $67.1K | ﹤0.01% |
1,629
-5,162
| -76% | -$229K |
|
3606
Opko Health
OPK
$921M
| $66.9K | ﹤0.01% |
41,810
+21,735
| +108% | +$39.6K |
|
3607
Verrica Pharmaceuticals
VRCA
$86.2M
| $65.6K | ﹤0.01% |
+1,687
| New | +$85.7K |
|
3608
Ultrapar
UGP
$6.87B
| $65.2K | ﹤0.01% |
+17,774
| New | +$67.7K |
|
3609
Caesarstone
CSTE
$72.3M
| $64.3K | ﹤0.01% |
+15,026
| New | +$72.4K |
|
|
LAZR
3610
CALL
DELISTED
Luminar Technologies
LAZR
| $63.7K | ﹤0.01% |
933
| – | – |
|
3611
Gogoro
GGR
$70.3M
| $62K | ﹤0.01% |
+1,183
| New | +$71.7K |
|
3612
CareCloud
CCLD
$94.3M
| $61.4K | ﹤0.01% |
53,404
+37,228
| +230% | +$78.3K |
|
3613
Companhia Siderúrgica Nacional
SID
$1.43B
| $61.3K | ﹤0.01% |
+25,666
| New | +$65.7K |
|
3614
Stoke Therapeutics
STOK
$1.82B
| $59.9K | ﹤0.01% |
+15,210
| New | +$100K |
|
3615
Epsilon Energy
EPSN
$176M
| $59.5K | ﹤0.01% |
11,273
+92
| +0.8% | +$513 |
|
3616
Veritone
VERI
$96.7M
| $58.4K | ﹤0.01% |
22,623
+6,112
| +37% | +$20.3K |
|
3617
Tilray
TLRY
$479M
| $58.2K | ﹤0.01% |
+2,436
| New | +$57.5K |
|
|
SRTA
3618
Strata Critical Medical Inc
SRTA
$436M
| $58.1K | ﹤0.01% |
22,422
+734
| +3% | +$2.58K |
|
3619
Imperial Petroleum
IMPP
$215M
| $57.6K | ﹤0.01% |
+36,449
| New | +$74.9K |
|
3620
AXT Inc
AXTI
$3.09B
| $56.2K | ﹤0.01% |
23,397
-20,508
| -47% | -$54.2K |
|
3621
PDS Biotechnology
PDSB
$38.1M
| $55.9K | ﹤0.01% |
11,076
-27,441
| -71% | -$150K |
|
3622
Televisa
TV
$1.45B
| $55.9K | ﹤0.01% |
18,326
-14,071
| -43% | -$61.8K |
|
|
NTBL
3623
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $55.4K | ﹤0.01% |
+6,492
| New | +$56.8K |
|
3624
Cipher Digital
CIFR
$9.47B
| $55.2K | ﹤0.01% |
+23,703
| New | +$80K |
|
|
RBOT
3625
DELISTED
Vicarious Surgical
RBOT
| $54.3K | ﹤0.01% |
+3,065
| New | +$112K |
|
Similar funds
Squarepoint's Q3 2023 Portfolio in Review
As of Q3 2023, Squarepoint held 4,410 positions worth $40.5B, up 24% from $32.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $9.9B of net new capital in Q3 2023, opening 905 new positions and adding to 1,516 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Adobe, an estimated $111M trimmed.
- Squarepoint's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
- Squarepoint added most to Tesla in Q3 2023, an estimated $184M increase.
- Squarepoint's biggest Q3 2023 reduction was Adobe, cutting an estimated $111M.
- Squarepoint fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2023, selling an estimated $56.4M.
- Squarepoint's ten largest holdings make up 11% of its $40.5B portfolio in Q3 2023.
- Squarepoint opened 905 new positions and closed 685 in Q3 2023.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $40.5B.
Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.